Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Join | Sign in
Home>Events

  Events

May 2014
Scientific News
Label-Free Binding Analysis Trends
Understand current trends and learn which application areas are expected to gain in popularity over the next few years.
Vitamin E Keeps Muscles Healthy
Body builders have it right: vitamin E does help build strong muscles, and scientists appear to have figured out one important way it does it.
Microchip Captures Clusters of Circulating Tumor Cells
Researchers have developed a microfluidic chip that can capture rare clusters of circulating tumor cells, which could yield important new insights into how cancer spreads.
New Method For Measuring The Concentration Of Medicines In The Blood
Researchers at EPFL have come up with a quick and portable new device for measuring the amount of medicinal drugs in blood.
Alternate Administration Routes for Psychotropic Drugs Reviewed
A review in the Annals of Pharmacotherapy has examined the literature on alternative routes of administration for antipsychotic and antidepressant medications.
Promising Results of Phase 1/2 Trial of Rociletinib in EGFR Lung Cancer Published
Results have been published of a multi-center phase I/II study of the investigational anti-cancer agent rociletinib in patients with EGFR-mutant non-small cell lung cancer (NSCLC) that had progressed after previous treatment with EGFR inhibitors.
Epilepsy Drug Metabolism Test Launched for Epilepsy and Seizure Disorders
Courtagen Life Sciences, Inc have announced the release of a NGS test focused on detection of anti-epileptic drug (AED) compatibilities and interactions for patients receiving treatment for epilepsy or other seizure disorders.
Supercooling May Aid Drug Delivery
A new study published is the first to break down the rules governing the complex process of crystallization through rapid-cooling.
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Neuropsychiatric Drug Candidate Shows Good Safety & Tolerability
Transition Therapeutics announces results from Phase 1 AME & renal clearance clinical studies of neuropsychiatric drug candidate ELND005.
06 May 2014 - 12 Jun 2014
Live-on-the-web
LC/MS Fundamentals and Applications
More information
06 May 2014 - 12 Jun 2014
Live-on-the-Web
Mass Spectral Interpretation
More information
07 May 2014 - 09 May 2014
Palm Beach, FL, USA
Evolution Summit 2014
More information
Controlled & Modified Drug Release 
07 May 2014 - 08 May 2014
Philadelphia University City Hotel, Philadelphia, PA, USA
Controlled & Modified Drug Release 
More information
11 May 2014 - 15 May 2014
Abu Dhabi, United Arab Emirates
Anthias Complete GC & GC-MS Course
More information
15 May 2014 - 16 May 2014
Philadelphia, PA, USA
4th Traceability & The Drug Quality and Security Act
More information
19 May 2014 - 21 May 2014
Paris, France
PharmAccess Leaders Forum
More information
19 May 2014 - 20 May 2014
Copenhagen, Denmark
Method Development and Optimization for LC/MS/MS
More information
21 May 2014 - 22 May 2014
Copenhagen, Denmark
Mass Spectral Interpretation
More information
<< 1 2 >>
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters